Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma

We characterized health-related quality of life (HRQoL), cognitive, and functional status in newly diagnosed glioblastoma (GBM) patients receiving Tumor treating fields (TTFields) with temozolomide (TMZ) versus TMZ alone in a planned interim analysis of a randomized phase III trial [NCT00916409], wh...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurooncol
Main Authors: Zhu, Jay-Jiguang, Demireva, Petya, Kanner, Andrew A., Pannullo, Susan, Mehdorn, Maximilian, Avgeropoulos, Nicholas, Salmaggi, Andrea, Silvani, Antonio, Goldlust, Samuel, David, Carlos, Benouaich-Amiel, Alexandra
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2017
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700237/
https://ncbi.nlm.nih.gov/pubmed/28849310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-017-2601-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares